Yaz and Clotting Dangers
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. In the years since its FDA approval, Yaz has been under attack for a troubling association with pulmonary embolism, stroke or heart attack. In 2003, the watchdog group Public Citizen was one of the first to demand that Yaz not is
Read MoreDilantin Linked to Birth Defects Such as Cleft Palate and Cleft Lip
This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm. Dilantin is a popular anti-epilepsy drug that is also widely used off-label for mood disorders and other conditions such as nerve pain, irregular heart rhythm, and migraines. There is growing scientific evidence that use of Dilantin is associated with birth defects
Read MoreDrug Spotlight: Effexor Birth Defect Dangers
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. From time to time, I update my blog with a spotlight on a particular drug in the news. Today’s entry will focus on the drug Effexor and the link to birth defects. Effexor is an antidepressant of the SNRI class manufactured
Read MoreConsumer Alert! Byetta Pancreatic Cancer Association
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. First Actos was linked to bladder cancer, now Byetta to pancreatic cancer. The diabetes drug Byetta has a long history of safety problems ranging from pancreatitis to renal failure. However, the warnings signs have taken on an entirely different meaning in
Read MoreConsumer Alert! Propecia and Sexual Dysfunction
Propecia is a “vanity drug” used to treat male pattern baldness. At the 360 Advocacy Conference at which I lectured in Chicago back in April of this year, I presented to my attorney colleagues the growing scientific evidence of Propecia’s association with sexual dysfunction. The bad news is that mounting evidence supports the conclusion that
Read MoreThe Fight for the Actos MDL Heats Up
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. As I predicted, the fight as to where the Actos bladder cancer MDL ends up just got a little more heated. Today, another dog entered the fight for the selection of MDL consolidation. An application was made to have the Actos
Read MoreConsumer Alert! More Bad News for Multaq
The news just keeps getting worse and worse for Multaq. Today the European Medicines Agency (EMA) expressed grave concerns over the safety of Multaq. This comes on the heels of highly vocal and pointed criticism of the safety profile of Multaq by Dr. Steve Nissen at the Cleveland Clinic. All of this, coupled with the
Read MoreConsumer Alert! Recalled Qualitest Birth Control Pills
If you are taking Qualitest Pharmaceuticals birth control pills, this is must-know information! Qualitest Pharmaceuticals is voluntarily recalling multiple lots of its birth control pills because of a packaging error that may leave women without adequate contraception and at risk for unintended pregnancy. It seems that the pill package was subject to a goof when
Read MoreMotion Filed to Consolidate Actos Bladder Cancer Cases in Illinois
This is Michael Brady Lynch, lead attorney for The Michael Brady Lynch Firm. I think this is a good development. In a somewhat unorthodox move given the relatively small number of cases on file, a motion to consolidate Actos bladder cancer cases for pre-trial proceedings and discovery before Judge G. Patrick Murphy in the Southern
Read MoreCancer Patients Taking Zofran Exposed to Fatal Heart Rhythms
This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm. Today, the FDA notified healthcare professionals and patients of an ongoing safety review and labeling changes for the anti-nausea drug Zofran. Zofran may increase the risk of developing prolongation of the QT interval of the electrocardiogram, which can lead to an
Read More